Phibro Animal Health (NASDAQ:PAHC) Trading Down 6.1% – What’s Next?

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) traded down 6.1% on Monday . The stock traded as low as $37.62 and last traded at $37.55. 120,852 shares were traded during mid-day trading, a decline of 59% from the average session volume of 293,232 shares. The stock had previously closed at $40.00.

Analyst Upgrades and Downgrades

PAHC has been the subject of several recent research reports. Citigroup initiated coverage on shares of Phibro Animal Health in a research report on Wednesday, April 15th. They set a “neutral” rating and a $62.00 target price for the company. Wall Street Zen cut shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Morgan Stanley set a $49.00 target price on shares of Phibro Animal Health in a research report on Friday, February 6th. Zacks Research upgraded shares of Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, March 11th. Finally, Weiss Ratings cut shares of Phibro Animal Health from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Phibro Animal Health currently has an average rating of “Hold” and a consensus price target of $42.40.

Phibro Animal Health Stock Down 9.2%

The firm’s 50-day simple moving average is $53.90 and its 200 day simple moving average is $46.51. The company has a market cap of $1.47 billion, a P/E ratio of 15.59, a PEG ratio of 0.61 and a beta of 0.61. The company has a debt-to-equity ratio of 1.97, a quick ratio of 1.26 and a current ratio of 3.17.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.72 by $0.04. The company had revenue of $383.54 million during the quarter, compared to analyst estimates of $367.02 million. Phibro Animal Health had a net margin of 6.35% and a return on equity of 37.14%. Phibro Animal Health has set its FY 2026 guidance at 2.980-3.100 EPS. On average, research analysts forecast that Phibro Animal Health Corporation will post 3.06 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 24th. Shareholders of record on Wednesday, June 3rd will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date of this dividend is Wednesday, June 3rd. Phibro Animal Health’s payout ratio is presently 20.60%.

Insider Transactions at Phibro Animal Health

In other Phibro Animal Health news, CEO Jack Bendheim sold 58,014 shares of the business’s stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $51.81, for a total value of $3,005,705.34. Following the completion of the transaction, the chief executive officer directly owned 64,944 shares of the company’s stock, valued at approximately $3,364,748.64. The trade was a 47.18% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders sold 182,326 shares of company stock valued at $9,584,712 over the last ninety days. 50.13% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in PAHC. 1620 Investment Advisors Inc. grew its stake in Phibro Animal Health by 77.4% in the fourth quarter. 1620 Investment Advisors Inc. now owns 676 shares of the company’s stock valued at $25,000 after acquiring an additional 295 shares during the period. Farther Finance Advisors LLC grew its stake in Phibro Animal Health by 113.2% in the fourth quarter. Farther Finance Advisors LLC now owns 727 shares of the company’s stock valued at $27,000 after acquiring an additional 386 shares during the period. KBC Group NV acquired a new position in Phibro Animal Health in the first quarter valued at about $29,000. Rothschild Investment LLC grew its stake in Phibro Animal Health by 2,500.0% in the fourth quarter. Rothschild Investment LLC now owns 1,040 shares of the company’s stock valued at $39,000 after acquiring an additional 1,000 shares during the period. Finally, Hughes Financial Services LLC acquired a new position in Phibro Animal Health in the third quarter valued at about $40,000. 99.34% of the stock is owned by institutional investors and hedge funds.

About Phibro Animal Health

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.